A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: Comparisons to a 4 h 51Cr-release assay

Journal of Immunological Methods

Volumn 325, Issue 1-2, 2007, Pages 51-66

  Kim, G G ^a   Donnenberg, V S ^a,b   Donnenberg, A D ^a,b   Gooding, W ^a   Whiteside, T L ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cell mediated cytotoxicity; Flow cytometry cytotoxicity (FCC); Lymphokine activated killer cells (LAK); Natural killer cells (NK)

Indexed keywords

TRACER;

ARTICLE; CANCER; CARCINOGENESIS; CELL DEATH; CHROMIUM 51 RELEASE; COMPARATIVE STUDY; CYTOLYSIS; CYTOTOXICITY; FLOW CYTOMETRY; IMMUNOPHENOTYPING; IMMUNOTHERAPY; LYMPHOKINE ACTIVATED KILLER CELL; MOLECULAR INTERACTION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; TARGET CELL;

ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD56; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL LINE, TUMOR; CHROMIUM RADIOISOTOPES; CYTOTOXICITY TESTS, IMMUNOLOGIC; DACTINOMYCIN; FLOW CYTOMETRY; FLUORESCENT DYES; GRANZYMES; HUMANS; IMMUNOPHENOTYPING; K562 CELLS; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; KINETICS; LEUKOCYTES, MONONUCLEAR; NEOPLASMS; RECEPTORS, IGG; REPRODUCIBILITY OF RESULTS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 34547769251     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2007.05.013     Document Type: Article

References (34)

1. Andersen M.H., Schrama D., Thor Straten P., and Becker J.C. Cytolytic T cells. J. Invest. Dermatol. 126 (2006) 32
2. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., and Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17 (1999) 189
3. Blomberg K., Granberg C., Hemmila I., and Lovgren T. Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence. J. Immunol. Methods 86 (1986) 225
4. Chahroudi A., Silvestri G., and Feinberg M.B. Measuring T cell-mediated cytotoxicity using fluorogenic caspase substrates. Methods 31 (2003) 120
5. Derby E., Reddy V., Baseler M., and Malyguine A. Flow cytometric assay for the simultaneous analysis of cell-mediated cytotoxicity and effector cell phenotype. BioTechniques 31 (2001) 660
6. Di Santo J.P. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24 (2006) 257
7. Goldberg J.E., Sherwood S.W., and Clayberger C. A novel method for measuring CTL and NK cell-mediated cytotoxicity using annexin V and two color flow cytometry. J. Immunol. Methods 224 (1999) 1
8. Graubert T.A., DePersio J.F., Russell J.H., and Ley T.J. Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J. Clin. Invest. 100 (1997) 904
9. Hasper H.J., Weghorst R.M., Richel D.J., Meerwaldt J.H., Olthuis F.M., and Schenkeveld C.E. A new four-color flow cytometric assay to detect apoptosis in lymphocyte subsets of cultured peripheral blood cells. Cytometry 40 (2000) 167
10. Hatam L., Schuval S., and Bonagura V.R. Flow cytometric analysis of natural killer cell function as a clinical assay. Cytometry 16 (1994) 59
11. Jedema I., van der Werff N.M., Barge R.M., Willemze R., and Falkenburg J.H. New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogenous target cell population. Blood 104 (2004) 2677
12. + T cell-mediated insulin-dependent diabetes mellitus. J. Immunol. 163 (1999) 4335
13. Kroesen B.J., Mesander G., Terhaar J.G., The T.H., and deLeij L. Direct visualization and quantification of cellular cytotoxicity using two colour fluorescence. J. Immunol. Meth. 156 (1992) 47
14. Lanier L.L. Natural killer cell receptor signaling. Curr. Opin. Immunol. 15 (2003) 308
15. Liu L., Chahroudi A., Silvestri G., Wernett M.E., Kaiser W.J., Safrit J.T., Komoriya A., Altman J.D., Packard B.Z., and Feinberg M.B. Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat. Med. 8 (2002) 185
16. Lukovic D., Komoriya A., Packard B.Z., and Ucker D.S. Caspase activity is not sufficient to execute cell death. Exp. Cell Res. 289 (2003) 384
17. Maino V.C., and Picker L.J. Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry 34 (1998) 207
18. Miller J.S., Soignier Y., Panoskaltsis-Mortari A., McNearney S.A., Yun G.H., Fautsch S.K., McKenna D., Le C., Defor T.E., Burns L.J., Orchard P.J., Blazar B.R., Wagner J.E., Slungaard A., Weisdorf D.J., Okazaki I.J., and McGlave P.B. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 105 (2003) 3051
19. Morales A., and Ottenhof P.C. Clinical application of a whole blood assay for human natural killer (NK) cell activity. Cancer 52 (1983) 667
20. Ozdemir O., Ravindranath Y., and Savasan S. Cell-mediated cytotoxicity evaluation using monoclonal antibody staining for target or effector cells with annexin V/propidium iodide colabeling by fluorosphere-adjusted counts on three-color flow cytometry. Cytometry Part A 56A (2003) 53
21. Perfetto S.P., Chattopadhyay P.K., Lamoreaux L., Nguyen R., Ambrozak D., Koup R.A., and Roederer M. Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. J. Immunol. Methods 313 (2006) 199
22. Roden M.M., Lee K.H., Panelli M., and Marincola F.M. A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology. J. Immunol. Methods 226 (1999) 29
23. Roder J.C., Haliotis T., Klein M., Korec S., Jett J.R., Ortaldo J., Herberman R.B., Katz P., and Fauci A.S. A new immunodeficiency disorder in humans involving NK cells. Nature 284 (1980) 553
24. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W.D., Tosti A., Posati S., Rogaia D., Frassoni F., Aversa F., Martelli M.F., and Velardi A. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097
25. Rutter C.M., and Elashof R.M. Analysis of longitudinal data: random coefficient regression modeling. Stat. Med. 13 (1994) 1211
26. Shresta S., Pham C.T., Thomas D.A., Graubert T.A., and Ley T.J. How do cytotoxic lymphocytes kill their targets?. Curr. Opin. Immunol. 10 (1998) 581
27. Smyth M.J., Crowe N.Y., Hayakawa K., Takeda H., Yagita H., and Godfrey D.I. NKT cells- conductors of tumor immunity. Curr. Opin. Immunol. 14 (2002) 165
28. Smyth M.J., Swann J., Kelly J.M., Cretney E., Yokoyama W.M., Diefenbach A., Sayers T.J., and Hayakawa Y. NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J. Exp. Med. 200 (2004) 1325
29. Telford W.G., Komoriya A., and Parckard B.Z. Multiparametric analysis of apoptosis by flow and image cytometry. Meth. Mol. Biol. 263 (2004) 141
30. Von Zons P., Crowley Novick P., Friberg D., Bell M., Koldovsky U., and Whiteside T.L. A comparison of europium-and chromium-release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma. Clin. Diag. Lam. Immunol. 4 (1997) 202
31. Whiteside T.L. ELISPOT Assays. In: Nagorsen D., and Marincola F.M. (Eds). Analyzing T Cell Responses (2005), Springer Publishers, Dordrecht, The Netherlands 143
32. Whiteside T.L., and Herberman R.B. Role of human natural killer cells in health and disease. Clin. Diag. Lab. Immunol. 1 (1994) 125
33. Whiteside T.L., and Herberman R.B. Role of natural killer cells in immune surveillance of cancer. Curr. Opin. Immunol. 7 (1995) 704
34. Whiteside T.L., Bryant J., Day R., and Herberman R.B. Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. J. Clin. Lab. Anal. 4 (1990) 102